Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Real-Time Image Guided Lymphatic Mapping and Nodal Targeting in Lung Cancer

This study is currently recruiting participants. (see Contacts and Locations)
Verified January 2016 by Dana-Farber Cancer Institute
Sponsor:
Collaborators:
Brigham and Women's Hospital
Beth Israel Deaconess Medical Center
Information provided by (Responsible Party):
Yolonda L. Colson, MD, PhD, Dana-Farber Cancer Institute
ClinicalTrials.gov Identifier:
NCT00264602
First received: December 12, 2005
Last updated: January 28, 2016
Last verified: January 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: January 2019
  Estimated Primary Completion Date: January 2018 (Final data collection date for primary outcome measure)